You are here

About SARC

Focused on Achieving Breakthroughs

SARC collaborators meet twice annually to discuss the latest therapies and concepts for new clinical trials. We are an open and transparent organization that welcomes ideas and encourages involvement from all of our members.

Other important SARC initiatives include the Career Development Award to foster innovative research by new investigators as well as the completed development of a research database to collect prospective data on these rare cancers.

In 2012, SARC received a Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI). This SARC Sarcoma SPORE grant provides $11.5 million over five years in support of laboratory and clinical scientists working collaboratively on sarcoma translational research.

Harnessing Scientific Expertise

To support our commitment to translational research, SARC has established the Clinical Research Committee (CRC) and the Developmental Therapeutics and Laboratory Research Committee (DTC). These committees along with the Director of Translational Research actively seek to identify new opportunities for collaboration within the SARC network. SARC encourages investigators and pharmaceutical companies to submit new ideas for collaborative research.